Traduction de «medicines and or health » (Néerlandais → Français) :

TERMINOLOGIE

periodiek onderzoek (jaarlijks)(lichamelijk) | 'health check-up' NNO
Bilan de santé SAI Examen périodique (annuel) (physique)

TRADUCTIONS EN CONTEXTE

Allied and Complementary Medicine Koninklijk Besluit Association des Chiropracticiens Belges Belgian School of Osteopathy (Wet) Beroepen in de Individuele Gezondheidszorg Bristish Medical Association Belgisch Staatsblad Complementary and Alternative Medicine Collège Belge d’Ostéopathie Council of Chiropractic Education Comité Européen de Normalisation/ European committee for Standardization Cumulative Index of Nursing and Allied Health Literature Centre for Reviews and Dissemination Debategraph Doctor in chiropractic Diplomed in osteopathy (USA: Doctor in osteopathy) Evidence Based Medicine European Council on Chiropractic Education European School of Osteopathy Flanders International College of Osteopathy Fonds voor Wetenschappelijk Onderzoek Facilitated Positional Release Graduate Education Program Groupement National Représentatif des Professionnels de l’Ostéopathie/ Groepering, Nationaal en Representatief van de Professionele Osteopaten Grading of Recommendations Assessment, Development and Evaluation High Velocity Low Amplitude International Academy of Osteopathy Intervalle de confiance/betrouwbaarheidsintervallen International Chiropractors Association Institut William Gardner Sutherland Muscle Energy Techniques Mean Weighted Difference National Institute for Health and Clinical Excellence Nederlands Register voor Osteopathie Non Steroidal Anti-inflammatory Drug Organisation Mondiale de la Santé Wereldgezondheidsorganisatie World Health Organisation Beroepscompetentieprofiel Physiotherapy Evidence Database Proprioceptive Neuromuscular Facilitation
Association Belge des Ostéopathes Classique / Belgische Associatie van Klassieke Osteopaten America Chiropractic Association Anglo-European College of Chiropractic Allied and Complementary Medicine Arrêté Royal Association des Chiropracticiens Belges Belgian School of Osteopathy (Wet) Beroepen in de Individuele Gezondheidszorg Bristish Medical Association Complementary and Alternative Medicine Collège Belge d’Ostéopathie Council of Chiropractic Education Comité Européen de Normalisation European committee for Standardization Cumulative Index of Nursing and Allied Health Literature Centre for Reviews and Dissemination Debategraph Doctor in chiropractic Diplomed in osteopathy (USA: Doctor in osteopathy) Evidence Based Medicine European Council on Chiropractic Education European School of Osteopathy Flanders International College of Osteopathy Fonds National de le Recherche Scientifique Facilitated Positional Release Graduate Education Program Groupement National Représentatif des Professionnels de l’Ostéopathie/ Groepering, Nationaal en Representatief van de Professionele Osteopaten Grading of Recommendations Assessment, Development and Evaluation High Velocity Low Amplitude International Academy of Osteopathy Intervalle de confiance International Chiropractors Association Institut William Gardner Sutherland Moniteur Belge Muscle Energy Techniques Mean Weighted Difference National Institute for Health and Clinical Excellence Nederlands Register voor Osteopathie Non Steroidal Anti-inflammatory Drug Organisation Mondiale de la Santé Profil de compétences professionnel Physiotherapy Evidence Database Proprioceptive Neuromuscular Facilitation Randomised Controlled Trial Roland Morris Disability Questionnaire

Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products
Law of 20 July 2006 on the establishment and functioning of the Federal Agency for Medicines and Health Products Royal decrees of 25 February 2007 on the composition and working method of the committees of the Federal Agency for Medicines and Health Products Royal decree of 20 December 2007 determining the date of establishment of the Scientific Committee, namely 1 February 2008 Royal decree of 28 January 2008 on the concrete composition of the Consultative Committee Ministerial decree of 11 January 2007 on the composition and appointment of the members of the executive board of the Federal Agency for Medicines and Health Products

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

Thus the FAHMP inspectors in the Production & Distribution department have a duty to control the relevant industry (medicines and health products), the blood establishments, the cell and tissue banks, the wholesale trade of medicines and health products, the retail and hospital pharmacies and the stocks of medicines at the veterinarians.
Thus the FAHMP inspectors in the Production & Distribution department have a duty to control the relevant industry (medicines and health products), the blood establishments, the cell and tissue banks, the wholesale trade of medicines and health products, the retail and hospital pharmacies and the stocks of medicines at the veterinarians.

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

Veterinary medicines The Veterinary Medicines unit ensures the quality, safety and efficacy of veterinary medicines in the interests of public health and animal welfare. This involves the following set of tasks: ●● Granting MA for veterinary medicines
Veterinary medicines The Veterinary Medicines unit ensures the quality, safety and efficacy of veterinary medicines in the interests of public health and animal welfare. This involves the following set of tasks: ●● Granting MA for veterinary medicines

Healthcare professionals and consumers of medicines and health products need to be made aware of the utility and obligation (in the case of materiovigilance and haemovigilance) of reporting adverse effects and adverse events associated with the use of medicines and health products to the FAMHP. Furthermore, the report form should be made easy to complete
Healthcare professionals and consumers of medicines and health products need to be made aware of the utility and obligation (in the case of materiovigilance and haemovigilance) of reporting adverse effects and adverse events associated with the use of medicines and health products to the FAMHP. Furthermore, the report form should be made easy to complete

The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.
The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.

Accupunctuur, chiropraxie, osteopathie en homeopathie zijn verschillende behandelingen die behoren tot de aanvullende, alternatieve geneeskunde Het National Center for Complementary and Alternative Medicine (NCCAM) van het National Institute of Health (US) definieert in 2007 deze geneeswijzen als een ««groep van verschillende medische systemen en gezondheidszorgen, praktijken en producten die momenteel niet worden beschouwd als deel uitmakende van de conventionele geneeskunde».
L’acupuncture, la chiropraxie, l’ostéopathie et l’homéopathie sont différentes modalités de traitement classées sous le label de médecines complémentaires et alternatives. Le National Center for Complementary and Alternative Medicine (NCCAM) du National Institute of Health (US) définit en 2007 ces médecines comme un “groupe de divers systèmes médicaux et de soins de santé, de pratiques et de produits qui ne sont pas actuellement considérés comme faisant partie de la médicine conventionnelle” b *.

Uiteraard valt er meer rond alternatieve geneeswijzen te zeggen dan de evaluatie van hun werkzaamheid (of niet) volgens de voor het KCE vertrouwde evidence-based medicine standaarden, zoveel was wel duidelijk.
Il paraissait évident en effet que l’analyse des médecines alternatives ne pouvait se limiter à leur éventuelle efficacité selon les schémas de l’evidence-based medicine familiers au KCE.